Mark D Long (Mark Long)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 40

Top Venues

Cancer research communications

Molecular cancer research : MCR

Nature communications

Cancers

Roswell Park Cancer Institute

University at Buffalo, State University of New York (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Roswell Park Cancer Institute Oct 24 2019

United States

Assistant Professor of Oncology :: Biostatistics & Bioinformatics

Roswell Park Cancer Institute Jul 05 2018 - Oct 23 2019

United States

Research Affiliate (Post Doctoral) :: Biostatistics & Bioinformatics

Roswell Park Cancer Institute Feb 18 2016 - Oct 23 2019

United States

Research Affiliate (Post Doctoral) :: Cancer Genetics

Education History

University at Buffalo, State University of New York Aug 21 2011 - Feb 18 2016

United States

PHD :: RPCI Division - Molecular Pharmacology & Cancer Therapeutics

University of Luxembourg Aug 21 2009 - Jul 21 2011

Luxembourg

MSC :: Systems Biology

University at Buffalo - The State University of New York Aug 21 2009 - Jul 21 2011

United States

MSC :: RPCI Division - Biological Sciences

SUNY Geneseo Aug 21 2004 - May 21 2008

United States

BSC :: Biology

Publications

Hirohito Ishigaki, Takayoshi Yamauchi, Mark D Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito
Generation, transcriptomic states, and clinical relevance of CX3CR1+ CD8 T cells in melanoma. Cancer research communications (2024)
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang, Tatsuaki Daimon, Hiroki Ozawa, Kazuhiro Matsumoto, Atsushi Fushimi, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Shimokawa, Shin Saito, Ann Marie Egloff, Ravindra Uppaluri, Mark D Long, Donald W Kufe
IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS. Cancer research communications (2024)
Hirohito Ishigaki, Takayoshi Yamauchi, Mark D Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito
Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. Cancer research communications 4 (7) (2024)
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang, Tatsuaki Daimon, Hiroki Ozawa, Kazuhiro Matsumoto, Atsushi Fushimi, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Shimokawa, Shin Saito, Ann Marie Egloff, Ravindra Uppaluri, Mark D Long, Donald W Kufe
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas. Cancer research communications 4 (5) (2024)
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang, Tatsuaki Daimon, Hiroki Ozawa, Kazuhiro Matsumoto, Atsushi Fushimi, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Shimokawa, Shin Saito, Ann Marie Egloff, Ravindra Uppaluri, Mark D Long, Donald W Kufe
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas. Cancer research communications 4 (5) (2024)
Shiqi Zhou, Yiting Song, Yuan Luo, Breandan Quinn, Yang Jiao, Mark D Long, Scott I Abrams, Jonathan F Lovell
Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen. Cancer research communications (2024)
Melissa Dolan, Yuhao Shi, Michalis Mastri, Mark D Long, Amber McKenery, James W Hill, Cristina Vaghi, Sebastien Benzekry, Joseph J Barbi, John M L Ebos
A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling. Molecular cancer therapeutics (2024)
Hirohito Ishigaki, Takayoshi Yamauchi, Mark D Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito
Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. Cancer research communications 4 (7) (2024)
Melissa Dolan, Yuhao Shi, Michalis Mastri, Mark D Long, Amber McKenery, James W Hill, Cristina Vaghi, Sebastien Benzekry, Joseph J Barbi, John M L Ebos
A senescence-mimicking (senomimetic) VEGFR TKI side-effect primes tumor immune responses via IFN/STING signaling. Molecular cancer therapeutics (2024)
Shiqi Zhou, Yiting Song, Yuan Luo, Breandan Quinn, Yang Jiao, Mark D Long, Scott I Abrams, Jonathan F Lovell
Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen. Cancer research communications 4 (4) (2024)
Shiqi Zhou, Yiting Song, Yuan Luo, Breandan Quinn, Yang Jiao, Mark D Long, Scott I Abrams, Jonathan F Lovell
Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen. Cancer research communications 4 (4) (2024)
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang, Tatsuaki Daimon, Hiroki Ozawa, Kazuhiro Matsumoto, Atsushi Fushimi, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Shimokawa, Shin Saito, Ann Marie Egloff, Ravindra Uppaluri, Mark D Long, Donald W Kufe
IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS. Cancer research communications (2024)
Bowen Dong, Natasa Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M Bonura, Cindy Sander, Henry G Withers, Mark D Long, Colin Chavel, Scott H Olejniczak, Hans Minderman, Joanne M Jeter, Robert P Edwards, Walter J Storkus, Pedro Romero, Pawel Kalinski
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer immunology research (2024)
Bowen Dong, Natasa Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M Bonura, Cindy Sander, Henry G Withers, Mark D Long, Colin Chavel, Scott H Olejniczak, Hans Minderman, Joanne M Jeter, Robert P Edwards, Walter J Storkus, Pedro Romero, Pawel Kalinski
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer immunology research (2024)
Hirohito Ishigaki, Takayoshi Yamauchi, Mark D Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito
Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. Cancer research communications 4 (7) (2024)
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang, Tatsuaki Daimon, Hiroki Ozawa, Kazuhiro Matsumoto, Atsushi Fushimi, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Shimokawa, Shin Saito, Ann Marie Egloff, Ravindra Uppaluri, Mark D Long, Donald W Kufe
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas. Cancer research communications 4 (5) (2024)
Manjunath Siddappa, Shahid Hussain, Sajad A Wani, Jason A White, Hancong Tang, Jaimie S Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D Long, Isra Elhussin, Balasubramanyanam Karanam, Honghe Wang, Rebecca Morgan, Gary Hardiman, Isaacson B Adelani, Solomon Oladapo Rotimi, Bernice Ofori, Larisa Nonn, Melissa B Davis, Rick A Kittles, Chanita Hughes Halbert, Lara E Sucheston-Campbell, Clayton C Yates, Moray J Campbell
African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A. Cancer research communications 3 (4) (2023)
Eihab Abdelfatah, Mark D Long, Ryutaro Kajihara, Takaaki Oba, Takayoshi Yamauchi, Hongbin Chen, Joy Sarkar, Kristopher M Attwood, Junko Matsuzaki, Brahm H Segal, Grace K Dy, Fumito Ito
Predictive and Prognostic Implications of Circulating CX3CR1 + CD8 + T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy. Cancer research communications 3 (3) (2023)
Manjunath Siddappa, Shahid Hussain, Sajad A Wani, Jason A White, Hancong Tang, Jaimie S Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D Long, Isra Elhussin, Balasubramanyanam Karanam, Honghe Wang, Rebecca Morgan, Gary Hardiman, Isaacson B Adelani, Solomon Oladapo Rotimi, Bernice Ofori, Larisa Nonn, Melissa B Davis, Rick A Kittles, Chanita Hughes Halbert, Lara E Sucheston-Campbell, Clayton C Yates, Moray J Campbell
African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A. Cancer research communications 3 (4) (2023)
Manjunath Siddappa, Shahid Hussain, Sajad A Wani, Jason A White, Hancong Tang, Jaimie S Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D Long, Isra Elhussin, Balasubramanyanam Karanam, Honghe Wang, Rebecca Morgan, Gary Hardiman, Isaacson B Adelani, Solomon Oladapo Rotimi, Bernice Ofori, Larisa Nonn, Melissa B Davis, Rick A Kittles, Chanita Hughes Halbert, Lara E Sucheston-Campbell, Clayton C Yates, Moray J Campbell
African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A. Cancer research communications 3 (4) (2023)
A J Robert McGray, Jessie L Chiello, Takemasa Tsuji, Mark D Long, Kathryn Maraszek, Nicole Gaulin, Spencer R Rosario, Suzanne M Hess, Scott I Abrams, Danuta Kozbor, Kunle Odunsi, Emese Zsiros
BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer control. Journal for immunotherapy of cancer 11 (6) (2023)
Manjunath Siddappa, Shahid Hussain, Sajad A Wani, Jason A White, Hancong Tang, Jaimie S Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D Long, Isra Elhussin, Balasubramanyanam Karanam, Honghe Wang, Rebecca Morgan, Gary Hardiman, Isaacson B Adelani, Solomon Oladapo Rotimi, Bernice Ofori, Larisa Nonn, Melissa B Davis, Rick A Kittles, Chanita Hughes Halbert, Lara E Sucheston-Campbell, Clayton C Yates, Moray J Campbell
African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A. Cancer research communications 3 (4) (2023)
Atrayee Bhattacharya, Atsushi Fushimi, Keyi Wang, Nami Yamashita, Yoshihiro Morimoto, Satoshi Ishikawa, Tatsuaki Daimon, Tao Liu, Song Liu, Mark D Long, Donald W Kufe
MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression. Communications biology 6 (1) (2023)
Xuedan He, Shiqi Zhou, Breandan Quinn, Dushyant Jahagirdar, Joaquin Ortega, Mark D Long, Scott I Abrams, Jonathan F Lovell
An In Vivo Screen to Identify Short Peptide Mimotopes with Enhanced Antitumor Immunogenicity. Cancer immunology research 10 (3) (2022)
Qianqian Zhu, Jie Wang, Han Yu, Qiang Hu, Nicholas W Bateman, Mark D Long, Spencer Rosario, Emily Schultz, Clifton L Dalgard, Matthew D Wilkerson, Gauthaman Sukumar, Ruea-Yea Huang, Jasmine Kaur, Shashikant B Lele, Emese Zsiros, Jeannine Villella, Amit Lugade, Kirsten Moysich, Thomas P Conrads, George L Maxwell, Kunle Odunsi
Whole-Genome Sequencing Identifies PPARGC1A as a Putative Modifier of Cancer Risk in BRCA1/2 Mutation Carriers. Cancers 14 (10) (2022)
Masayuki Hagiwara, Atsushi Fushimi, Atrayee Bhattacharya, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Oya, Henry G Withers, Qiang Hu, Tao Liu, Song Liu, Kwok-Kin Wong, Mark D Long, Donald W Kufe
MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer. Oncoimmunology 11 (1) (2022)
Atrayee Bhattacharya, Atsushi Fushimi, Nami Yamashita, Masayuki Hagiwara, Yoshihiro Morimoto, Hasan Rajabi, Mark D Long, Maha Abdulla, Rehan Ahmad, Kelly Street, Song Liu, Tao Liu, Donald W Kufe
MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells. Molecular cancer research : MCR 20 (4) (2022)
Atsushi Fushimi, Yoshihiro Morimoto, Satoshi Ishikawa, Nami Yamashita, Atrayee Bhattacharya, Tatsuaki Daimon, Hasan Rajabi, Caining Jin, Masayuki Hagiwara, Yota Yasumizu, Zhou Luan, Wenhao Suo, Kwok-Kin Wong, Henry G Withers, Song Liu, Mark D Long, Donald W Kufe
Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer. Molecular cancer research : MCR 20 (9) (2022)
Spencer R Rosario, Justine J Jacobi, Mark D Long, Hayley C Affronti, Aryn M Rowsam, Dominic J Smiraglia
JAZF1: A Master Metabolic Regulator of Sensitivity to a Polyamine Targeted Therapy. Molecular cancer research : MCR (2022)
Nami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi, Rehan Ahmad, Atrayee Bhattacharya, Tatsuaki Daimon, Naoki Haratake, Yuka Inoue, Satoshi Ishikawa, Masaaki Yamamoto, Tsuyoshi Hata, Sayuri Akiyoshi, Qiang Hu, Tao Liu, Henry G Withers, Song Liu, Geoffrey I Shapiro, Tomoharu Yoshizumi, Mark D Long, Donald W Kufe
MUC1-C Dictates PBRM1-Mediate Chronic Induction of Interferon Signaling, DNA Damage Resistance and Immunosuppression in Triple-Negative Breast Cancer. Molecular cancer research : MCR (2022)
Nami Yamashita, Atsushi Fushimi, Yoshihiro Morimoto, Atrayee Bhattacharya, Masayuki Hagiwara, Masaaki Yamamoto, Tsuyoshi Hata, Geoffrey I Shapiro, Mark D Long, Song Liu, Donald W Kufe
Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer. Cancers 14 (11) (2022)
Mark K Farrugia, Mark D Long, David M Mattson, Leayn T Flaherty, Bowen Dong, Eduardo Cortes Gomez, Lei Wei, Agnieszka K Witkiewicz, Song Yao, Pawel Kalinski, Anurag K Singh
Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy. Cancers 13 (2) (2021)
Kaiwen Li, Tiancheng Li, Zhaoyi Feng, Mei Huang, Lei Wei, Zhiyu Yan, Mark D Long, Qiang Hu, Jianmin Wang, Song Liu, Dennis C Sgroi, Shadhmer Demehri
CD8+ T cell immunity blocks the metastasis of carcinogen-exposed breast cancer. Science advances 7 (25) (2021)
Masayuki Hagiwara, Atsushi Fushimi, Nami Yamashita, Atrayee Bhattacharya, Hasan Rajabi, Mark D Long, Yota Yasumizu, Mototsugu Oya, Song Liu, Donald W Kufe
MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells. Oncogene 40 (30) (2021)
Yixuan Zhou, Ingmar Niels Bastian, Mark D Long, Michelle Dow, Weihua Li, Tao Liu, Rachael Katie Ngu, Laura Antonucci, Jian Yu Huang, Qui T Phung, Xi-He Zhao, Sourav Banerjee, Xue-Jia Lin, Hongxia Wang, Brian Dang, Sylvia Choi, Daniel Karin, Hua Su, Mark H Ellisman, Christina Jamieson, Marcus Bosenberg, Zhang Cheng, Johannes Haybaeck, Lukas Kenner, Kathleen M Fisch, Richard Bourgon, Genevive Hernandez, Jennie R Lill, Song Liu, Hannah Carter, Ira Mellman, Michael Karin, Shabnam Shalapour
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation. Proceedings of the National Academy of Sciences of the United States of America 118 (8) (2021)
Hayley C Affronti, Aryn M Rowsam, Anthony J Pellerite, Spencer R Rosario, Mark D Long, Justine J Jacobi, Anna Bianchi-Smiraglia, Christoph S Boerlin, Bryan M Gillard, Ellen Karasik, Barbara A Foster, Michael Moser, John H Wilton, Kristopher Attwood, Mikhail A Nikiforov, Gissou Azabdaftari, Roberto Pili, James G Phillips, Robert A Casero, Dominic J Smiraglia
Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy. Nature communications 11 (1) (2020)
Yota Yasumizu, Hasan Rajabi, Caining Jin, Tsuyoshi Hata, Sean Pitroda, Mark D Long, Masayuki Hagiwara, Wei Li, Qiang Hu, Song Liu, Nami Yamashita, Atsushi Fushimi, Ling Kui, Mehmet Samur, Masaaki Yamamoto, Yan Zhang, Ning Zhang, Deli Hong, Takahiro Maeda, Takeo Kosaka, Kwok-Kin Wong, Mototsugu Oya, Donald W Kufe
Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nature communications 11 (1) (2020)
Takaaki Oba, Mark D Long, Tibor Keler, Henry C Marsh, Hans Minderman, Scott I Abrams, Song Liu, Fumito Ito
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s. Nature communications 11 (1) (2020)
Yota Yasumizu, Hasan Rajabi, Caining Jin, Tsuyoshi Hata, Sean Pitroda, Mark D Long, Masayuki Hagiwara, Wei Li, Qiang Hu, Song Liu, Nami Yamashita, Atsushi Fushimi, Ling Kui, Mehmet Samur, Masaaki Yamamoto, Yan Zhang, Ning Zhang, Deli Hong, Takahiro Maeda, Takeo Kosaka, Kwok-Kin Wong, Mototsugu Oya, Donald W Kufe
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nature communications 11 (1) (2020)
Hasan Rajabi, Tsuyoshi Hata, Wei Li, Mark D Long, Qiang Hu, Song Liu, Deepak Raina, Ling Kui, Yota Yasumizu, Deli Hong, Mehmet Samur, Donald W Kufe
MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells. Oncogene 38 (47) (2019)

Mark D Long.css-eqlu8i{font-size:small;padding-left:4px;} (Mark Long)

Publication Activity (10 Years)

Top Topics

Top Venues

Mark D Long (Mark Long)